Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The function of lymphocytes in normal and suppressed hematopoiesis.

× No keyword cloud information.

56 in total

1. [Toxicity of human leucocyte interferon preparations in human bone-marrow cultures].

Authors: C Nissen; B Speck; G Emödi; N N Iscove
Journal: Lancet Date: 1977-01-22 Impact factor: 79.321

2. Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial.

Authors: R Champlin; W Ho; R P Gale
Journal: N Engl J Med Date: 1983-01-20 Impact factor: 91.245

3. Antithymocyte globulin reacts with many normal human cell types.

Authors: B Greco; L Bielory; D Stephany; S M Hsu; P Gascon; A Nienhuis; N Young
Journal: Blood Date: 1983-11 Impact factor: 22.113

4. Effect of antilymphocyte globulin on granulocyte precursors in aplastic anaemia.

Authors: A Faille; A J Barrett; N Balitrand; F Ketels; E Gluckman; Y Najean
Journal: Br J Haematol Date: 1979-07 Impact factor: 6.998

5. Human erythroid burst-forming units. Growth in vitro is dependent on monocytes, but not T lymphocytes.

Authors: K S Zuckerman
Journal: J Clin Invest Date: 1981-03 Impact factor: 14.808

6. In vitro tests for distinguishing possible immune-mediated aplastic anemia from transfusion-induced sensitization.

Authors: B J Torok-Storb; C Sieff; R Storb; J Adamson; E D Thomas
Journal: Blood Date: 1980-02 Impact factor: 22.113

7. The regulation of haemopoiesis in long-term bone marrow cultures: I. role of L-cell CSF.

Authors: T M Dexter; R K Shadduck
Journal: J Cell Physiol Date: 1980-03 Impact factor: 6.384

8. Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera.

Authors: C J Eaves; A C Eaves
Journal: Blood Date: 1978-12 Impact factor: 22.113

9. Generation of CFU-C suppressor T cells in vitro. V. A multistep process.

Authors: A Bacigalupo; M Podesta'; F Frassoni; G Piaggio; M T Van Lint; M R Raffo; M Repetto; A Marmont
Journal: Br J Haematol Date: 1982-11 Impact factor: 6.998

10. A survey of the effectiveness of cyclophosphamide in patients with severe aplastic anemia.

Authors: P F Griner
Journal: Am J Hematol Date: 1980 Impact factor: 10.047

5 in total

1. Lymphocyte subpopulations in solvent-exposed workers.

Authors: W Denkhaus; D von Steldern; U Botzenhardt; H Konietzko
Journal: Int Arch Occup Environ Health Date: 1986 Impact factor: 3.015

2. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo.

Authors: N C Zoumbos; P Gascon; J Y Djeu; N S Young
Journal: Proc Natl Acad Sci U S A Date: 1985-01 Impact factor: 11.205

3. Anaemia in juvenile chronic arthritis: serum inhibition of normal erythropoiesis in vitro.

Authors: P J Prouse; A R Harvey; B Bonner; C D Reid; B M Ansell; M Gumpel
Journal: Ann Rheum Dis Date: 1987-02 Impact factor: 19.103

4. Modulation of inflammasome-mediated pulmonary immune activation by type I IFNs protects bone marrow homeostasis during systemic responses to Pneumocystis lung infection.

Authors: Steve Searles; Katherine Gauss; Michelle Wilkison; Teri R Hoyt; Erin Dobrinen; Nicole Meissner
Journal: J Immunol Date: 2013-08-23 Impact factor: 5.422

5. Cyclosporine A treatment in four cases of aplastic anemia.

Authors: A Porwit; P Panayotides; E Mansson; E Osby; R Hast; P Reizenstein
Journal: Blut Date: 1987-02

5 in total